Takeda Says FDA Committee Indicates Recommendation for Peginesatide

Takeda Pharmaceutical announced on December 8 that the Oncologic Drugs Advisory Committee of the US Food and Drug Administration (FDA) had indicated that it will make a recommendation for the marketing approval for renal anemia treatment peginesatide (generic name), which...read more